This study aims to demonstrate a potential association between gut microbiota composition, plasma levels of various forms of vitamin K, and severity of clinical manifestations of Pseudoxanthoma Elasticum (PXE).
Vitamin K deficiency contributes to pathological calcification which underlies the clinical picture of pseudoxanthoma elasticum (PXE), an inherited autosomal recessive disease. A substantial proportion of vitamin K, namely the K2 form (menaquinones), is produced by gut microbiota. In healthy volunteers fecal levels of the major menaquinone producers, Escherichia coli and Bacteroides species, are approximately 5 and 9 log10 CFU/g dry weight respectively. There is however a lack of data on gut microbiota in PXE patients. The objective of our project is to demonstrate a potential association between gut microbiota composition, plasma levels of various forms of vitamin K and severity of clinical manifestations in PXE patients. This study will be performed as Research surrounding bio collection "Clinical and biological exploration of PXE patients" kept at the Center of Biological Resources of Angers University Hospital (bio collection n° DC 20116-14-67, authorization to transfer n° 2016-27-99). Fecal samples, plasma samples and clinical data will be collected from patients diagnosed with PXE who will be monitored at the Angers University Hospital Referral Center (France) in 2019-2020. Clinical severity of PXE will be assessed using modified Phenodex score. Gut microbiota will be analyzed using metagenomic sequencing. Plasma Vitamin K species and fecal excretion of menaquinones will be assessed using HPLC. Plasma dp-ucMGP (circulating biomarker of vitamin K status) and serum PIVKA-II (protein induced by vitamin K absence-II) will be assessed using immunoassay. Results will be compared to healthy age- and gender-matched controls from the pre-existing Biofortis database.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
20
Fecal samples for intestinal microbiota analysis; Blood and fecal samples for assessment of various forms of vitamin K
Biofortis Mérieux NutriSciences
Saint-Herblain, Pays de la Loire Region, France
ACTIVE_NOT_RECRUITINGDepartment of Dermatology, University Hospital of Angers
Angers, Pays de Loire, France
RECRUITINGDepartment of Biochemistry, University Maastricht
Maastricht, Netherlands
ACTIVE_NOT_RECRUITINGFecal samples for intestinal microbiota analysis
Gut microbiota composition and relative abundance of species (via metagenomic sequencing)
Time frame: 15 min
Fecal samples for assessment of various forms of vitamin K
Fecal Vitamin K species
Time frame: 15 min
Blood samples for assessment of various forms of vitamin K
Plasma Vitamin K species
Time frame: 15 min
Blood samples for assessment of dp-ucMGP
Plasma dp-ucMGP
Time frame: 15 min
Blood samples for assessment of PIVKA-II
Serum PIVKA-II
Time frame: 15 min
Severity of ocular and cardiovascular PXE manifestations and extent of PXE skin changes
Modified Phenodex score: * Skin lesions severity: S0=No sign; S1= Papules/bumps; S2= Plaques of coalesced papules; S3= Lax and redundant skin * Number of affected skin sites: for Typical and Nontypical areas * Ophthalmological involvement: E0= No sign; E1= Peau d'orange ; E2= Angioid streaks; E3a=Medical history of bleeding and/or scarring; E3b= Unilateral or bilateral blindness * Gastrointestinal bleeding: G0= No sign; G1= Gastrointestinal bleeding as related to PXE * Vascular involvement: V0= No sign; V1= Weak or absent pulse or peripheral artery disease revealed by vascular imaging; V2= Intermittent claudication; V3= Medical history of vascular surgery or Stroke/TIA * Cardiac involvement: C0= No sign; C1= medical history of chest pain/angina/abnormal EKG or abnormal stress test with no symptom, or Mitral insufficiency; C2= Heart attack * Renal involvement: R0= No sign; R1a= asymptomatic nephrocalcinosis revealed by imaging; R1b= Nephrolithiasis
Time frame: 15 min
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.